Logo image of RKLB

ROCKET LAB USA INC (RKLB) Stock Fundamental Analysis

NASDAQ:RKLB - Nasdaq - US7731221062 - Common Stock - Currency: USD

28.98  -0.45 (-1.53%)

After market: 28.9 -0.08 (-0.28%)

Fundamental Rating

3

Overall RKLB gets a fundamental rating of 3 out of 10. We evaluated RKLB against 65 industry peers in the Aerospace & Defense industry. While RKLB seems to be doing ok healthwise, there are quite some concerns on its profitability. RKLB shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year RKLB has reported negative net income.
In the past year RKLB has reported a negative cash flow from operations.
In the past 5 years RKLB always reported negative net income.
RKLB had a negative operating cash flow in each of the past 5 years.
RKLB Yearly Net Income VS EBIT VS OCF VS FCFRKLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 -50M -100M -150M

1.2 Ratios

With a Return On Assets value of -16.33%, RKLB is not doing good in the industry: 73.44% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -44.86%, RKLB is doing worse than 68.75% of the companies in the same industry.
Industry RankSector Rank
ROA -16.33%
ROE -44.86%
ROIC N/A
ROA(3y)-15.03%
ROA(5y)-17.99%
ROE(3y)-23.3%
ROE(5y)-28.61%
ROIC(3y)N/A
ROIC(5y)N/A
RKLB Yearly ROA, ROE, ROICRKLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 -10 -20 -30 -40 -50

1.3 Margins

RKLB has a Gross Margin (26.06%) which is comparable to the rest of the industry.
The Profit Margin and Operating Margin are not available for RKLB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 26.06%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
RKLB Yearly Profit, Operating, Gross MarginsRKLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 0 -50 -100 -150

More info and screens

5

2. Health

2.1 Basic Checks

RKLB does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for RKLB has been increased compared to 1 year ago.
The debt/assets ratio for RKLB is higher compared to a year ago.
RKLB Yearly Shares OutstandingRKLB Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 100M 200M 300M 400M
RKLB Yearly Total Debt VS Total AssetsRKLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 11.34 indicates that RKLB is not in any danger for bankruptcy at the moment.
RKLB's Altman-Z score of 11.34 is amongst the best of the industry. RKLB outperforms 93.75% of its industry peers.
RKLB has a Debt/Equity ratio of 0.97. This is a neutral value indicating RKLB is somewhat dependend on debt financing.
RKLB has a worse Debt to Equity ratio (0.97) than 75.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Altman-Z 11.34
ROIC/WACCN/A
WACC10.23%
RKLB Yearly LT Debt VS Equity VS FCFRKLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 0 200M 400M 600M

2.3 Liquidity

RKLB has a Current Ratio of 2.58. This indicates that RKLB is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 2.58, RKLB is doing good in the industry, outperforming 62.50% of the companies in the same industry.
RKLB has a Quick Ratio of 2.16. This indicates that RKLB is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.16, RKLB is in the better half of the industry, outperforming 76.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 2.16
RKLB Yearly Current Assets VS Current LiabilitesRKLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

7

3. Growth

3.1 Past

RKLB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -2.78%.
The Revenue has grown by 53.92% in the past year. This is a very strong growth!
The Revenue has been growing by 90.82% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-2.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
Revenue 1Y (TTM)53.92%
Revenue growth 3Y90.82%
Revenue growth 5YN/A
Sales Q2Q%54.9%

3.2 Future

Based on estimates for the next years, RKLB will show a very strong growth in Earnings Per Share. The EPS will grow by 28.98% on average per year.
RKLB is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 45.04% yearly.
EPS Next Y-2.45%
EPS Next 2Y7.45%
EPS Next 3Y22.63%
EPS Next 5Y28.98%
Revenue Next Year75.18%
Revenue Next 2Y56.04%
Revenue Next 3Y55.14%
Revenue Next 5Y45.04%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
RKLB Yearly Revenue VS EstimatesRKLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 500M 1B 1.5B 2B 2.5B
RKLB Yearly EPS VS EstimatesRKLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

RKLB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RKLB. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RKLB Price Earnings VS Forward Price EarningsRKLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RKLB Per share dataRKLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 0.6 0.8

4.3 Compensation for Growth

A more expensive valuation may be justified as RKLB's earnings are expected to grow with 22.63% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.45%
EPS Next 3Y22.63%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RKLB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROCKET LAB USA INC

NASDAQ:RKLB (1/28/2025, 8:01:22 PM)

After market: 28.9 -0.08 (-0.28%)

28.98

-0.45 (-1.53%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)11-12 2024-11-12/amc
Earnings (Next)N/A N/A
Inst Owners52.85%
Inst Owner Change0.15%
Ins Owners10.95%
Ins Owner Change28.49%
Market Cap14.48B
Analysts79
Price Target23.74 (-18.08%)
Short Float %12.03%
Short Ratio2.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.53%
Min EPS beat(2)12.21%
Max EPS beat(2)22.86%
EPS beat(4)4
Avg EPS beat(4)13.03%
Min EPS beat(4)0.3%
Max EPS beat(4)22.86%
EPS beat(8)5
Avg EPS beat(8)5.69%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-0.38%
Min Revenue beat(2)-1.23%
Max Revenue beat(2)0.46%
Revenue beat(4)1
Avg Revenue beat(4)-2.88%
Min Revenue beat(4)-6.48%
Max Revenue beat(4)0.46%
Revenue beat(8)3
Avg Revenue beat(8)-1.25%
Revenue beat(12)6
Avg Revenue beat(12)1.01%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)5.13%
PT rev (3m)199.33%
EPS NQ rev (1m)0%
EPS NQ rev (3m)4.69%
EPS NY rev (1m)0%
EPS NY rev (3m)2.14%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)10.62%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)2.6%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 39.8
P/FCF N/A
P/OCF N/A
P/B 34.49
P/tB 50.42
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.32
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.73
BVpS0.84
TBVpS0.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -16.33%
ROE -44.86%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 26.06%
FCFM N/A
ROA(3y)-15.03%
ROA(5y)-17.99%
ROE(3y)-23.3%
ROE(5y)-28.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 171.22%
Cap/Sales 15.38%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.58
Quick Ratio 2.16
Altman-Z 11.34
F-Score6
WACC10.23%
ROIC/WACCN/A
Cap/Depr(3y)187.47%
Cap/Depr(5y)250.93%
Cap/Sales(3y)27.93%
Cap/Sales(5y)39.56%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-2.78%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-25%
EPS Next Y-2.45%
EPS Next 2Y7.45%
EPS Next 3Y22.63%
EPS Next 5Y28.98%
Revenue 1Y (TTM)53.92%
Revenue growth 3Y90.82%
Revenue growth 5YN/A
Sales Q2Q%54.9%
Revenue Next Year75.18%
Revenue Next 2Y56.04%
Revenue Next 3Y55.14%
Revenue Next 5Y45.04%
EBIT growth 1Y-11.28%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year39.82%
EBIT Next 3Y36.16%
EBIT Next 5Y37.04%
FCF growth 1Y4.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.98%
OCF growth 3YN/A
OCF growth 5YN/A